International Business News - MYL http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Three companies have sued Mylan Inc. over its filing to make generic versions of the muscle-relaxant Amrix, Mylan said Monday. Cephalon Inc., Eurand Inc. and Anesta AG all have sued over the abbreviated new drug application to make cyclobenzaprine hydrochloride extended-release capsules. http://www.ibtimes.com/articles/20081201/companies-sue-mylan-over-generic-version-of-amrix.htm Mon, 01 Dec 2008 09:12:42 EST Two generic drug developers said Wednesday they are challenging the patent on the extended-release muscle-relaxant Amrix, and biotechnology company Cephalon Inc. is filing a lawsuit to halt sales of the drug. http://www.ibtimes.com/articles/20081126/cephalon-sues-generic-companies-over-patents.htm Wed, 26 Nov 2008 14:06:31 EST Drugmaker Mylan Inc. said Tuesday its Mylan Pharmaceuticals unit received final regulatory approval for an application to use fluoxetine capsules for the treatment of a premenstrual disorder. http://www.ibtimes.com/articles/20081118/mylan-fda-oks-application-for-fluoxetine-capsules.htm Tue, 18 Nov 2008 08:52:53 EST Mylan Inc. said Monday the Food and Drug Administration tentatively approved the drug developer's generic capsule version of Wyeth's antidepressant Effexor XR. http://www.ibtimes.com/articles/20081117/mylan-gets-tentative-fda-ok-on-antidepressant.htm Mon, 17 Nov 2008 08:34:00 EST U.S. Attorneys in New Jersey on Friday filed a lawsuit seeking a shutdown of three Actavis Inc. plants until they are brought into compliance with testing, manufacturing laws and FDA regulations. http://www.ibtimes.com/articles/20081114/attorneys-move-to-close-actavis-nj-facilities.htm Fri, 14 Nov 2008 17:16:53 EST With Barack Obama's election to the White House and Democrats expanding their majorities in Congress, the nation's health care companies face the biggest threat to their profits in over a decade. http://www.ibtimes.com/articles/20081105/health-care-reform-may-hurt-drugmakers-insurers.htm Wed, 05 Nov 2008 13:07:42 EST Drugmaker Mylan Inc. said it has received approval to market a generic version of UCB's epilepsy drug Keppra, and has started shipping the drug. Mylan, based in Canonsburg, Pa., said the Food and Drug Administration approved its application to market generic versions of the drug, also called Levetiracetam, in 250 milligram, 500 mg and 750 mg tablets. It said U.S. sales of Keppra totaled about $1 billion in the 12 months ended Sept. 30. http://www.ibtimes.com/articles/20081104/mylan-launches-generic-of-ucb-epilepsy-drug-keppra.htm Tue, 04 Nov 2008 17:27:15 EST Battered by the financial meltdown, America's business community is anxiously calculating how Tuesday's presidential election will affect it. Energy, pharmaceutical and telecommunications companies could face tax and other policy changes no matter who wins the White House. The outcome also could determine how well alternative energy developers, generic biotechnology companies, stem cell researchers and others fare. http://www.ibtimes.com/articles/20081102/election-to-benefit-some-industries-harm-others.htm Sun, 02 Nov 2008 11:39:46 EST Among the earnings projection stories for Thursday, Oct. 30, from AP Financial News: CLEVELAND (AP)--Lubrizol Corp. reaffirmed its full-year adjusted earnings forecast Thursday within the range of analysts' estimates. http://www.ibtimes.com/articles/20081030/outlook-roundup-lubrizol-mylan.htm Thu, 30 Oct 2008 14:27:43 EDT Mylan Inc. raised its full-year profit estimate far above analyst expectations Thursday, after the drugmaker reported its third-quarter results. Mylan said it now expects to earn between 64 cents and 67 cents per share in 2008, up from a range of 47 cents to 53 cents per share. On average, Thomson Reuters said analysts were expecting 50 cents per share. Both estimates exclude one-time gains and costs. http://www.ibtimes.com/articles/20081030/mylan-boosts-2008-outlook-backs-2009-10-forecasts.htm Thu, 30 Oct 2008 13:09:58 EDT Drugmaker Mylan Inc. said Thursday its third-quarter profit grew 15 percent due to sales from the Merck KGaA generic business, which it bought last year, and deferred revenue from the sale of a blood pressure drug. http://www.ibtimes.com/articles/20081030/mylan-3q-profit-up-15-percent-on-generic-sales.htm Thu, 30 Oct 2008 13:06:46 EDT Mylan Inc. said Wednesday it received tentative approval from the Food and Drug Administration for a generic version of Sanofi Aventis' prostate drug Uroxatral ER. http://www.ibtimes.com/articles/20081022/mylan-gets-tentative-fda-ok-on-prostate-drug.htm Wed, 22 Oct 2008 10:30:53 EDT Mylan Inc. said Wednesday it received tentative approval from the Food and Drug Administration for a generic version of Daiichi Sankyo's blood-pressure drug Benicar HCT. http://www.ibtimes.com/articles/20081022/mylan-gets-tentative-fda-ok-on-blood-pressure-drug.htm Wed, 22 Oct 2008 10:12:35 EDT Mylan Inc. said Wednesday it has been accused of patent infringement by Novartis AG over Mylan's generic version of the Swiss company's Lescol capsules for treating high cholesterol. http://www.ibtimes.com/articles/20081022/novartis-sues-mylan-over-generic-version-of-lescol.htm Wed, 22 Oct 2008 09:20:23 EDT Mylan Inc. is seeking to market a generic version of the skeletal muscle relaxant Amrix, the makers of the drug, Cephalon Inc. and Eurand NV, said Tuesday. http://www.ibtimes.com/articles/20081021/mylan-asks-fda-to-approve-generic-form-of-amrix.htm Tue, 21 Oct 2008 12:03:02 EDT Drug developer Mylan Inc. said Thursday it completed $500 million of interest rate swaps in a move meant to take advantage of a decline in medium-term interest rates. http://www.ibtimes.com/articles/20081009/mylan-completes-500-million-interest-rate-swap.htm Thu, 09 Oct 2008 08:01:45 EDT A Wachovia analyst upgraded the generic drug sector on Monday, and raised his ratings on Teva Pharmaceutical Industries Ltd. and Watson Pharmaceuticals Inc. because they are trading at discounts to their peers. http://www.ibtimes.com/articles/20080922/ahead-of-the-bell-generic-drug-makers.htm Mon, 22 Sep 2008 09:18:29 EDT A wave of consolidation that has reshaped the generic drug industry in recent years will continue, experts say, as companies like Teva Pharmaceutical Industries and Mylan Inc. compete for new business in emerging global markets. http://www.ibtimes.com/articles/20080919/more-consolidation-seen-in-generic-drug-industry.htm Fri, 19 Sep 2008 16:20:02 EDT Expanding the use of low-cost generic pharmaceuticals would be near the top of the health care agendas of both Barack Obama and John McCain if elected in November, advisers for the presidential contenders said Thursday. http://www.ibtimes.com/articles/20080918/obama-mccain-advisers-agree-on-generic-drugs.htm Thu, 18 Sep 2008 14:23:31 EDT Among the stock activity stories for Wednesday, Sept. 17, from AP Financial News: NEW YORK (AP)--Shares of Adobe Systems Inc. ticked higher Wednesday, bucking the overall market, after the maker of design software's latest quarterly results and guidance beat estimates. http://www.ibtimes.com/articles/20080917/movers-roundup-adobe-systems-penske.htm Wed, 17 Sep 2008 14:21:27 EDT